Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06972641
What this trial is testing

Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
AMLMDS
Ruijin Hospital 126
Large-scale testing (Phase 3)UnknownNCT05907486
What this trial is testing

The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Thrombotic Disorder
The First Affiliated Hospital of Soochow University 260
Not applicableUnknownNCT04078399
What this trial is testing

Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence

Who this might be right for
HSCTEfficacy and Safety
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Early research (Phase 1)Ended earlyNCT03286114
What this trial is testing

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia
University of Michigan Rogel Cancer Center 16
Large-scale testing (Phase 3)UnknownNCT01959100
What this trial is testing

Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Malignant Hematological Diseases
Assistance Publique - Hôpitaux de Paris 480
Testing effectiveness (Phase 2)Ended earlyNCT00579111
What this trial is testing

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Who this might be right for
Myelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Baylor College of Medicine 4
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Not applicableNot Yet RecruitingNCT06385808
What this trial is testing

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Who this might be right for
Relapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more
First Affiliated Hospital Xi'an Jiaotong University 37
Testing effectiveness (Phase 2)Study completedNCT00802568
What this trial is testing

Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Institut Paoli-Calmettes 48
Early research (Phase 1)Active Not RecruitingNCT03922035
What this trial is testing

CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 36
Testing effectiveness (Phase 2)UnknownNCT05559450
What this trial is testing

Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 80
Testing effectiveness (Phase 2)Ended earlyNCT00075023
What this trial is testing

Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis

Who this might be right for
Graft-versus-Host DiseaseStomatitis
National Institute of Nursing Research (NINR) 10
Not applicableWithdrawnNCT03121079
What this trial is testing

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Who this might be right for
Interferon-A-2BRelapsePrevention+1 more
Peking University People's Hospital
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Not applicableUnknownNCT03272789
What this trial is testing

Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells

Who this might be right for
Haematologic Disease (Cancer)Onco-coaching of Sport- Inspirated
Institut Paoli-Calmettes 32
Large-scale testing (Phase 3)Study completedNCT02670252
What this trial is testing

BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationBusulfanTotal Body Irradiation+1 more
Nanfang Hospital, Southern Medical University 550
Early research (Phase 1)Study completedNCT03600155
What this trial is testing

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Temporarily pausedNCT02988258
What this trial is testing

Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT

Who this might be right for
Haematological MalignanciesCMV Infection
University College, London 10
Not applicableUnknownNCT03534674
What this trial is testing

Vitamin D3 Supplementation for AlloHSCT-RCT

Who this might be right for
Vitamin D Deficiency
University of British Columbia 84
Testing effectiveness (Phase 2)Looking for participantsNCT07185633
What this trial is testing

Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease

Who this might be right for
aGVHD
Bin Gu 25
Next Page